SEARCH

SEARCH BY CITATION

References

  • 1
    Pagliaro L, D'Amico G, Pasta L, Tinè F, Aragona E, Politi F, Malizia G. Efficacy and efficiency of treatments in portal hypertension. In: de FranchisR, ed. Portal Hypertension II. Proceedings of the second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science, 1996:159179.
  • 2
    El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000; 95:35663573.
    Direct Link:
  • 3
    Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98:653659.
    Direct Link:
  • 4
    McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49:682685.
  • 5
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietrni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646649.
  • 6
    The Italian Liver Cirrhosis Project. Reliability of endoscopy in the assessment of variceal features. J Hepatol 1987; 4:9398.
  • 7
    de Franchis R, Pascal J, Ancona E, Burroughs AK, Henderson M, Fleig W, Groszmann R, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop. Baveno, Lake Maggiore, Italy, April 5-6, 1990. J Hepatol 1992; 15:256261.
  • 8
    de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996; 25:390394.
  • 9
    Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation. II. Analysis and examples. Br J Cancer 1977; 35:139.
  • 10
    Breslow NE, Day NE. Statistical methods in cancer research. Vol. II 1987. Lyon: International Agency for Research on Cancer.
  • 11
    Poynard T, Chaput JC, Mary JY, Scolaro L, Buffet C, Etienne JP. Analyse critique des facteurs lié au trentiéme jour dans les hemorrhagies digestives hautes du cirrhotique. Gastroenterol Clin Biol 1980; 4:655665.
  • 12
    Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80:800809.
  • 13
    Christensen E, Faverholdt L, Schlichting P, Juhl P, Poulsen H, Tygstrup N. Aspects of natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisolone. Gastroenterology 1981; 81:944952.
  • 14
    Garden OJ, Motyl H, Gilmour WH, Utley RJ, Carter DC. Prediction of outcome following acute variceal hemorrhage. Br J Surg 1985; 72:9195.
  • 15
    D'Amico G, Morabito A, Pagliaro L. Six-week prognostic indicators in upper gastrointestinal hemorrhage in cirrhosis. In: DianzaniMU, GenntiliniP, eds. Frontiers in Gastrointestinal Research: Chronic Liver Disease. Basel: Karger, 1986:247257.
  • 16
    de Dombal FT, Clarke JR, Clamp SE, Malizia G, Kotwal MR, Morgan AG. Prognostic factors in upper G.I. bleeding. Endoscopy 1986; 18(Suppl 2):610.
  • 17
    Melchior JC, Poupon RE, Verrier J, Merrer J, Moncorge C, Simon N. Analyse des facteurs liés è la mortalité précoce au cours des hémorragies dues à l'hypertension portale. Gastroenterol Clin Biol 1987; 11:402408.
  • 18
    Burroughs AK, Mezzanotte G, Phillips A, McCormick A, McIntire N. Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology 1989; 9:801807.
  • 19
    Ohmann C, Stoltzing H, Wins L. Prognostic scores in oesophageal or gastric variceal bleeding. Scand J Gastroenterol 1990; 25:501512.
  • 20
    Siringo S, McCormick PA, Mistry P, Kaye G, McIntyre N, Burroughs AK. Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc 1991; 37:5155.
  • 21
    Le Moine O, Adler M, Burgeois N, Delhaye M, Deviare J, Gelin M, Vandermeeren A, et al. Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut 1992; 33:13811385.
  • 22
    Gatta A, Merkel C, Amodio P, Bellon S, Bellumat A, Bolognesi M, Borsato L, et al. Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. Am J Gastroenterol 1994: 89:15281536.
  • 23
    Ben-Ari Z, Cardin F, McCormick AP, Wannamathee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceal bleeding. J Hepatol 1999; 31:443450.
  • 24
    Harrell FE Jr, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems and suggested solutions. Cancer Treat Rep 1985; 69:10711077.
  • 25
    Hanley JA, McNeil BJ. The meaning and the use of the area under the receiver operating characteristic (ROC) curve. Radiology 1982; 143:2936.
  • 26
    Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839843.
  • 27
    D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence based approach. Semin Liver Dis 1999; 19:475505.
  • 28
    Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29:16551661.
  • 29
    Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002; 2:CD002907.
  • 30
    Knottnerus JA, van Weel C, Muris JWM. Evidence base of clinical diagnosis. Evaluation of diagnostic procedures. BMJ 2002; 324:477480.